Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands and with operational headquarters in Hatfield, Hertfordshire in the United Kingdom. In 2007, Mylan acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients (APIs) for generic drugs, and the generics business of Germany-based Merck KGaA.
| Attributes | Values |
|---|---|
| rdfs:comment |
|
| foaf:name |
|
| foaf:homepage | |
| foaf:depiction | |
| assets ($) |
|
| equity ($) |
|
| foundation place | |
| founded by | |
| founding year |
|
| industry | |
| key person | |
| location | |
| net income ($) |
|
| number of employees |
|
| operating income ($) |
|
| product | |
| revenue ($) |
|
| thumbnail | |
| type | |
| is parent company of |